Hsin-Ell Wang
Overview
Explore the profile of Hsin-Ell Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
1078
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chuang C, Cheng T, Chen W, Huang Y, Wang H, Lo Y, et al.
Front Microbiol
. 2022 Nov;
13:896588.
PMID: 36406412
Hepatitis C virus (HCV) NS3/4A protease is an attractive target for direct-acting antiviral agents. Real-time tracking of the NS3/4A protease distribution and activity is useful for clinical diagnosis and disease...
2.
Chan H, Lo Y, Chang D, Li J, Chang W, Chen C, et al.
Gels
. 2022 Mar;
8(3).
PMID: 35323293
Transarterial radioembolization (TARE) is an emerging treatment for patients with unresectable hepatocellular carcinoma (HCC). This study successfully developed radiometal-labeled chitosan microspheres (111In/177Lu-DTPA-CMS) with a diameter of 36.5 ± 5.3 μm...
3.
Chen C, Chen C, Li J, Chen Y, Wang C, Wang Y, et al.
ACS Appl Bio Mater
. 2022 Jan;
2(8):3573-3581.
PMID: 35030743
The efficacy of gold nanoparticle (AuNP)-assisted radiofrequency (RF)-induced hyperthermia employing the Kanzius device remains controversial. Different from the Kanzius device, modulated electro-hyperthermia (mEHT) utilizes the capacitive-impedance coupled 13.56 MHz radiofrequency...
4.
Lo Y, Chang T, Chen C, Lin M, Wang H, Chang C, et al.
Int J Mol Sci
. 2021 Jul;
22(12).
PMID: 34208566
Regarding the increased incidence and high mortality rate of malignant melanoma, practical early-detection methods are essential to improve patients' clinical outcomes. In this study, we successfully prepared novel picolinamide-benzamide (F-FPABZA)...
5.
Chen C, Chen Y, Lo Y, Lin M, Chang C, Chen C, et al.
Int J Mol Sci
. 2020 Sep;
21(18).
PMID: 32916962
Malignant melanoma is the most harmful type of skin cancer and its incidence has increased in this past decade. Early diagnosis and treatment are urgently desired. In this study, we...
6.
Chang S, Chen C, Lin J, Wang H, Mori S, Li J, et al.
Cells
. 2020 May;
9(5).
PMID: 32397494
Microbial proteins have recently been found to have more benefits in clinical disease treatment because of their better-developed strategy and properties than traditional medicine. In this study, we investigated the...
7.
Chen S, Sun J, Chen B, Lin S, Chang H, Collins S, et al.
Int J Mol Sci
. 2020 Feb;
21(4).
PMID: 32093290
Prodrug activator gene therapy mediated by murine leukemia virus (MLV)-based retroviral replicating vectors (RRV) was previously shown to be highly effective in killing glioma cells both in culture and in...
8.
Hsu S, Chen Y, Chiang H, Huang Y, Huang C, Wang H, et al.
J Neurooncol
. 2020 Feb;
146(3):417-426.
PMID: 32020472
Introduction: The failure of immune checkpoint inhibitor (ICPi) on glioblastoma (GBM) treatment underscores the need for improving therapeutic strategy. We aimed to change tumor associated macrophage (TAM) from M2 type...
9.
Chen C, Chang D, Li J, Chan H, Chen J, Chang C, et al.
J Mater Chem B
. 2019 Nov;
8(1):65-77.
PMID: 31768514
Gold nanostars (AuNSs), with unique physicochemical properties, are thought to be a promising agent for photothermal therapy (PTT). In this study, we prepared PEGylated gold nanostars (pAuNSs) using the HEPES-reduction...
10.
Juang V, Chang C, Wang C, Wang H, Lo Y
Small
. 2019 Nov;
15(49):e1903296.
PMID: 31709707
Irinotecan is one of the main chemotherapeutic agents for colorectal cancer (CRC). MicroRNA-200 (miR-200) has been reported to inhibit metastasis in cancer cells. Herein, pH-sensitive and peptide-modified liposomes and solid...